Return On Assets of Cyclo Therapeutics, Inc. from 31 Dec 2012 to 30 Sep 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Cyclo Therapeutics, Inc. quarterly and annual Return On Assets in % history and change rate from 31 Dec 2012 to 30 Sep 2024.
  • Cyclo Therapeutics, Inc. Return On Assets for the quarter ending 30 Sep 2024 was -326%, a 22% increase year-over-year.
  • Cyclo Therapeutics, Inc. annual Return On Assets for 2023 was -291%, a 90% decline from 2022.
  • Cyclo Therapeutics, Inc. annual Return On Assets for 2022 was -153%, a 68% decline from 2021.
  • Cyclo Therapeutics, Inc. annual Return On Assets for 2021 was -91%, a 42% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Cyclo Therapeutics, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2024 -326% +92% +22% 01 Jul 2024 30 Sep 2024
Q2 2024 -270% +82% +23% 01 Apr 2024 30 Jun 2024
Q1 2024 -253% -6% -2.5% 01 Jan 2024 31 Mar 2024
Q4 2023 -291% -138% -90% 01 Oct 2023 31 Dec 2023
Q3 2023 -418% -323% -340% 01 Jul 2023 30 Sep 2023
Q2 2023 -352% -264% -299% 01 Apr 2023 30 Jun 2023
Q1 2023 -247% -161% -188% 01 Jan 2023 31 Mar 2023
Q4 2022 -153% -62% -68% 01 Oct 2022 31 Dec 2022
Q3 2022 -95% +3% +3.2% 01 Jul 2022 30 Sep 2022
Q2 2022 -88% +4% +4.8% 01 Apr 2022 30 Jun 2022
Q1 2022 -86% +21% +20% 01 Jan 2022 31 Mar 2022
Q4 2021 -91% +66% +42% 01 Oct 2021 31 Dec 2021
Q3 2021 -98% +180% +65% 01 Jul 2021 30 Sep 2021
Q2 2021 -93% +158% +63% 01 Apr 2021 30 Jun 2021
Q1 2021 -107% +60% +36% 01 Jan 2021 31 Mar 2021
Q4 2020 -156% -2% -1.1% 01 Oct 2020 31 Dec 2020
Q3 2020 -278% -141% -103% 01 Jul 2020 30 Sep 2020
Q2 2020 -250% -98% -65% 01 Apr 2020 30 Jun 2020
Q1 2020 -166% +71% +30% 01 Jan 2020 31 Mar 2020
Q4 2019 -155% +46% +23% 01 Oct 2019 31 Dec 2019
Q3 2019 -137% +86% +39% 01 Jul 2019 30 Sep 2019
Q2 2019 -152% +55% +27% 01 Apr 2019 30 Jun 2019
Q1 2019 -238% -52% -28% 01 Jan 2019 31 Mar 2019
Q4 2018 -201% -33% -20% 01 Oct 2018 31 Dec 2018
Q3 2018 -223% -76% -52% 01 Jul 2018 30 Sep 2018
Q2 2018 -207% -36% -21% 01 Apr 2018 30 Jun 2018
Q1 2018 -186% -45% -32% 01 Jan 2018 31 Mar 2018
Q4 2017 -168% -48% -40% 01 Oct 2017 31 Dec 2017
Q3 2017 -147% -42% -41% 01 Jul 2017 30 Sep 2017
Q2 2017 -171% -98% -134% 01 Apr 2017 30 Jun 2017
Q1 2017 -141% -81% -135% 01 Jan 2017 31 Mar 2017
Q4 2016 -120% -69% -134% 01 Oct 2016 31 Dec 2016
Q3 2016 -105% -69% -196% 01 Jul 2016 30 Sep 2016
Q2 2016 -73% -48% -188% 01 Apr 2016 30 Jun 2016
Q1 2016 -60% -38% -177% 01 Jan 2016 31 Mar 2016
Q4 2015 -51% -38% -295% 01 Oct 2015 31 Dec 2015
Q3 2015 -35% -26% -289% 01 Jul 2015 30 Sep 2015
Q2 2015 -25% -18% -254% 01 Apr 2015 30 Jun 2015
Q1 2015 -22% -28% -457% 01 Jan 2015 31 Mar 2015
Q4 2014 -13% -20% -280% 01 Oct 2014 31 Dec 2014
Q3 2014 -9% -24% -161% 01 Jul 2014 30 Sep 2014
Q2 2014 -7% -24% -142% 01 Apr 2014 30 Jun 2014
Q1 2014 6% +1% +11% 01 Jan 2014 31 Mar 2014
Q4 2013 7% +4% +163% 01 Oct 2013 31 Dec 2013
Q3 2013 15% 01 Jul 2013 30 Sep 2013
Q2 2013 17% 01 Apr 2013 30 Jun 2013
Q1 2013 6% 01 Jan 2013 31 Mar 2013
Q4 2012 3% 01 Oct 2012 31 Dec 2012

Cyclo Therapeutics, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2023 -291% -138% -90% 01 Jan 2023 31 Dec 2023
2022 -153% -62% -68% 01 Jan 2022 31 Dec 2022
2021 -91% +66% +42% 01 Jan 2021 31 Dec 2021
2020 -156% -2% -1.1% 01 Jan 2020 31 Dec 2020
2019 -155% +46% +23% 01 Jan 2019 31 Dec 2019
2018 -201% -33% -20% 01 Jan 2018 31 Dec 2018
2017 -168% -48% -40% 01 Jan 2017 31 Dec 2017
2016 -120% -69% -134% 01 Jan 2016 31 Dec 2016
2015 -51% -38% -295% 01 Jan 2015 31 Dec 2015
2014 -13% -20% -280% 01 Jan 2014 31 Dec 2014
2013 7% +4% +163% 01 Jan 2013 31 Dec 2013
2012 3% 01 Jan 2012 31 Dec 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.